Case Group AB
F:V9E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Case Group AB
F:V9E
|
SE |
|
N
|
Nuvo Pharmaceuticals Inc
F:23N
|
CA |
|
Lagardere SA
PAR:MMB
|
FR |
|
Lifeline SPAC I Oyj
F:0CD
|
FI |
|
Secom Co Ltd
F:XSC
|
JP |
|
E
|
Equinix Inc
F:EQN2
|
US |
|
C
|
CME Group Inc
XMUN:MX4A
|
US |
|
F
|
First Industrial Realty Trust Inc
F:F5W
|
US |
|
S
|
Salesforce Inc
DUS:FOO
|
US |
Intrinsic Value
The intrinsic value for Case Group AB (V9E) under the Base Case is hidden EUR. Compared with the current market price of 1.72 EUR, the stock appears hidden .
Do our valuations actually work? See backtest results .
V9E looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if V9E is one of them.
See where today’s valuation sits in V9E’s own history and what typically happened over the next 12 months after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Case Group AB.
The intrinsic value for Case Group AB (V9E) under the Base Case is hidden EUR.
Compared with the current market price of 1.72 EUR, the stock appears hidden.
